Return to content in this issue

 

A Tailored 7- to 10-Day Lenalidomide Desensitization Protocol

Pose K1, Narváez-Fernández E1, López de la Guía A2, De Las Vecillas L1,3, Domínguez-Ortega J1,3,4, Lluch-Bernal M1,3, Fiandor A1,3, Cabañas R1,3,5,6

1Department of Allergy, La Paz University Hospital, Madrid, Spain
2Department of Hematology, La Paz University Hospital, Madrid, Spain
3La Paz Institute for Health Research (IdiPAZ), Madrid, Spain
4CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain
5PIELenRed Consortium
6Centro de Investigación en Red de Enfermedades Raras (CIBERER, U754)

J Investig Allergol Clin Immunol 2024; Vol 34(1) : 49-50
doi: 10.18176/jiaci.0914

Key words: Desensitization protocol, Lenalidomide, Drug-induced hypersensitivity syndrome